Camille N. Abboud, MD

Camille N. Abboud, MD

Professor

Address:
Division of Oncology
Mail Stop 8007-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110

11th Floor Mid Campus Center (office)

Admin:
Gina Gentilini
ggentilini@wustl.edu

Clinical Interests
  • Acute & chronic leukemia
  • Myelodysplastic syndrome
  • Myeloproliferative disorders
  • Lymphoma
  • Myeloma
Research

My principal role is to participate and design novel translational research clinical trials focusing on patients with Hematologic Malignancies and Myeloproliferative Neoplasms within our combined Leukemia and BMT program in the Division of Oncology at Washington University. Apart from the multiple trials active at the Siteman Cancer Center I served as P.I. and co-P.I. on Phase I and Phase II AML, MDS, Lymphoma, GVHD, BMT Stem Cell Mobilization Treatment and Supportive Care Clinical trials. I have a focus on clinical trials in CML (Bosutinib, Asciminib), and in collaboration with Dr. Stephen Oh (Hematology) have focused on novel therapies for Myelofibrosis, and combined epigenetic therapy and targeted therapy (JAK inhibitors) to bridge MDS/MPN patients to allogeneic stem cell transplantation with a goal to minimize graft failure and acute GVHD in MF. I am the P.I. on a novel radiolabeled anti CD45 antibody to optimize allogeneic SCT in relapsed refractory AML patients (Sierra Phase 3 Trial of Iomab-B). I am involved in patient care and teaching of residents and fellows rotating in Oncology.

Profiles (publications)
WU Physician Bio

Biosketch

Education

  • 1974: MD, American University of Beirut School of Medicine, Lebanon
  • 1970: BS (with honors), American University of Beirut, Lebanon

Post-Graduate Training

  • 1980-1979: Senior Instructor in Hematology, Department of Medicine, University of Rochester School of Medicine, Rochester, NY
  • 1979-1977: Research Fellow in Hematology, Department of Medicine, University of Rochester School of Medicine, Rochester, NY
  • 1977-1976: Clinical Fellow in Hematology, Department of Medicine, University of Rochester School of Medicine, Rochester, NY
  • 1976-1974: Resident in Medicine, College of Medicine & Dentistry of New Jersery and Rutgers Medical School, Piscataway, NJ
  • 1974-1973: Straight Medical Intern, American University Hospital, Beirut

Academic Positions & Employment

  • present-2007: Professor of Medicine, Washington University School of Medicine, St. Louis, MO
  • 2007-1995: Professor of Medicine, University of Rochester, Rochester, NY
  • 1995-1986: Associate Professor of Medicine, University of Rochester, Rochester, NY
  • 1986-1980: Assistant Professor of Medicine, University of Rochester, Rochester, NY
  • 1980-1979: Senior Instructor in Medicine, University of Rochester, Rochester, NY
  • 1979-1976: Instructor in Medicine, University of Rochester, Rochester, NY

Editorial Boards

  • 2011-2009: Editorial Board, Advances in Hematology
  • 1994-1992: Editorial Board, Experimental Hematology

Board Certification

  • 1978: Hematology (ABIM)
  • 1976: American Board of Internal Medicine

Other Experience & Professional Memberships

  • present-2010: NCCN Acute Myeloid Leukemia Panel Member
  • present-2010: NCCN Chronic Myelogenous Leukemia Panel Member
  • present-2009: ASH Scholar Award Study Section member
  • present-1996: American Association of Cancer Research
  • present-1994: American Society for Blood & Marrow Transplantation
  • present-1993: International Society for Cellular Therapy (formerly ISAGE)
  • present-1992: American Society of Clinical Oncology
  • present-1981: American Society of Hematology
  • present-1980: International Society for Experimental Hematology
  • present-1979: American College of Physicians
  • 2016: NIAID-DAIT-NIH-AI-2015042 BAA, “Development of Radiation/Nuclear Medical Countermeasures or Biodosimetry Devices”, reviewer
  • 2012: NIAID-DAIT-11-033 RFA, “Predictive Biodosimetry: Discovery and Development of Biomarkers for Acute and Delayed Radiation Injuries”, reviewer
  • 2011-2007: Leukemia & Lymphoma Society, Translational Review Panel
  • 2010: NCI Cancer Center Grant, Ad Hoc reviewer
  • 2009: NIAID, reviewer of RFP-NIAID-DAIT-NIHAI2008023, “Studies of Immunosenescence and Other Late Effects of Acute Ionizing Radiation Exposure in Atomic Bomb Survivors”
  • 2009: NCI- ARRA Grand Opportunities- “Stem Cells/Cell Biology”, Ad Hoc reviewer
  • 2008: NCI, reviewer, “Tumor Stem Cells in Cancer Biology, Prevention, and Therapy”, RO1, RFA: CA 08-019
  • 2008: NCI, reviewer, “Tumor Stem Cells in Cancer Biology, Prevention, and Therapy”, RO1, RFA: CA 08-020
  • 2005: NCI, reviewer of Centers for Medical Countermeasures Against Radiation
  • 2005: NCI, PO1 reviewer, Gene Therapy Cluster Review, Cellular Transduction in Cancer
  • 2004-2003: NCI, Clinical Oncology Study Section, Quick Trials for Novel Cancer Therapies, reviewer
  • 2004-1990: Society of Leukocyte Biology
  • 2004-1980: American Association for the Advancement of Science
  • 2004-1980: American Federation for Clinical Research
  • 2004: NIAID, reviewer of PO1, “Myeloid Progenitor Cell Therapy for Radiation Exposure”
  • 2002-1979: New York Academy of Science
  • 2001-1995: Armed Forces Breast Cancer Grants, “Pathobiology panel” (ad hoc reviewer)
  • 2000-1995: Member, Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) Inspection Committee
  • 1998: NIHLBI, “A Related Umbilical Cord Blood Bank for Hemoglobinopathy Patients”, Chairman
  • 1997: NIHLBI, NIDDK, “Homing of Stem/Progenitor Cells”, Bethesda, RFA #HLA-96-020
  • 1997: NIHLBI, “Gene Transfer Principles of Heart, Lung, and Blood Diseases”, RFA #HL-96-019
  • 1997: NCI, reviewer of PO1, “Breast Cancer Chemotherapy and Vaccines”
  • 1996: NIHLB, ad hoc reviewer for PO1 on Stem Cells and Cell Cycle, Bethesda
  • 1996: NCI, “Studies of the Viral Etiology of AIDS-Associated Malignancies”, RFA #CA-96-08
  • 1995: NIHLB (reviewer): SCORs on Stem Cell Biology, RFA-NIH-94-HL-10-B
  • 1995: American Cancer Society Immunology Study Section (reviewer)
  • 1995: NIHLB, ad hoc reviewer for PO1 on Stem Cells, Johns Hopkins site visit
  • 1995: NIHLB: “Cytokine Effects on Hematopoiesis in AIDS Animal Models”, RFA-HL-95-09B
  • 1994-1992: NIH, DRG, ad hoc reviewer K21 grants
  • 1994: American Cancer Society (outside ad hoc reviewer), Immunology Section
  • 1994: NIHLB and NIADDK (reviewer), “In-Utero Transplantation” RFA and “Hematologic Consequences of HIV Infection of Marrow Cells” RFA-HL-94-04-B
  • 1992: ACS Advisory Committee on Drug Development, Hematology and Pathology
  • 1992: National Institute of Health Lung and Blood (reviewer), Sickle Cell Center
  • 1991-1988: Chemotherapy and Hematology
  • 1990: National Institute of Health Lung and Blood (reviewer), Stem Cell Biology RFA
  • 1988-1982: United Cancer Council
  • 1987-1985: Ad Hoc Member, ACS Advisory Committee on Clinical Investigation

Honors & Awards

  • 1982: Bushwell Fellow, University of Rochester
  • 1982-1981: Sinsheimer Award, University of Rochester
  • 1979-1977: NIH Training Grant, University of Rochester